 MOUNTAIN VIEW, Calif., Nov. 05, 2020 GLOBE NEWSWIRE -- - Initial D ata from Phase 1 T rial of IGM-2323 in R elapsed r efractory N on-Hodgkins L ymphoma to be Presented at the 62nd American Society of Hematology Annual Meeting and Exposition in December - 